S7 E3: There's no such thing as a compliant venue
Rina & Jean discuss the criteria in determing if a meeting is compliant. Venue is only one!
4 Juni 2min
S7 E2: "Every breath matters" - does that promote a specific medicine?
Rina & Jean discuss a recently published PMCPA ruling vs GSK about their corporate ad - placed before a finance podcast for the public. Was this actually promotion to the public or genuinely good corp...
28 Maj 2min
S7 E1: How Theramex walked away from PMCPA jurisdiction and what it means for pharma self-regulation
Theramex is the third UK pharma company to leave PMCPA jurisdiction in three years (Sandoz 2023, Evolus 2024, Theramex 2026). Does that reflect increasing rules, companies avoiding audit, or self-regu...
21 Maj 5min
S6 E8: Why Skills Matter in AQP and Signatory Roles
Competence is not just about job titles. Rina & Jean discuss why real skills and practical experience remain essential to understanding the INTENT behind the Code to applying JUDGEMENT in complex appr...
9 Mars 3min
S6 E7: Global Voices, UK Rules: When Senior Leaders Speak to the Media
In this episode, Rina and Jean discuss what happens when senior global leaders speak about medicines in UK national media - and why even well-intentioned interviews can cross into promotion of prescri...
2 Mars 3min
S6 E6: “The Best” isn’t balanced: Patient Testimony and Three AZ Video Breaches
Patient stories are powerful and that’s exactly why pharma want to use them. In this episode, Rina and Jean analyse three AstraZeneca videos that used patient testimony describing treatment as “the be...
23 Feb 2min
S6 E5: Social Media, Pharma and the PMCPA: Three Changes You Really Need to Know
In this episode, Rina and Jean dissect the new PMCPA social media guidance and highlight three key changes that add clarity for pharma companies. Essential listening for anyone signing off or posting ...
16 Feb 3min
S6 E4: What’s in the Package? PMCPA’s New Deal on Package Deals
The PMCPA has published 14 page guidance on Package Deals. We cut through the fluff and tell you what you need to know & why reviewing existing arrangements now matters for compliance and transparency...
9 Feb 3min
